Gut microbes implicated in bladder cancer
Science & Technology Study shows that gut bacteria can metabolise carcinogens and cause them to accumulate in distant organs, leading to tumour development.
2024
science-technology
Read the latest Issue
New funding scheme to strengthen infection biology research across Europe
EMBL Announcements EMBL and partners announce ‘Amplifying Funds in Infection Biology’ to foster interdisciplinary and collaborative research in infection biology.
2024
embl-announcements
Exploring microbial life in context
Science & Technology EMBL researchers and their partners have been studying microbial functions and interactions for the benefit of human and planetary health for the last two decades.
2024
science-technology
Case study: Discovering new enzymes to upcycle food waste
Science & Technology EMBL-EBI data resource helps scientists upcycle animal by-products.
2024
perspectivesscience-technology
We are EMBL: Jacqueline Toussaint on strange bacteria and bioinformatics
Lab MattersPeople & Perspectives Jacqueline shares her experience of EMBL's international PhD programme.
2024
lab-matterspeople-perspectives
Hamburg collaboration paves the way to cleaner technologies for industry
Science & Technology An interdisciplinary collaboration between Hamburg scientists has yielded new insights into the structure and function of a heat-resistant enzyme from an exotic microbe. In this interview, EMBL Hamburg’s Matthias Wilmanns and TUHH’s Garo Antranikian discuss how their collaboration developed and…
2023
sciencescience-technology
EMBL scientists receive prestigious ERC Synergy Grants
EMBL Announcements Jan Kosinski, Julia Mahamid, and Georg Zeller have received grants to enable ambitious projects aimed at mapping the cellular protein synthesis machinery in context and understanding complex host-microbiome interactions, respectively.
2023
embl-announcementsscience
Six symposium takeaways about human microbiome research
Science & Technology Here are six takeaways from a recent EMBO/EMBL symposium that brought together scientists to discuss the state of research involving the human microbiome and its connection to health and disease.
2023
eventsscience-technology
Fighting antimicrobial resistance with new drug combinations
Science & Technology In an extensive investigation, EMBL researchers have tested over 10,000 drug combinations against some of the leading pathogenic bacteria carrying antimicrobial resistance and causing mortality.
2023
sciencescience-technology
ERC starting grants for two EMBL Heidelberg researchers
EMBL AnnouncementsLab Matters Jordi van Gestel and Maria Zimmermann-Kogadeeva each receive 1.5 million EUR funding for research projects on microbial predators and the gut microbiome respectively
2023
embl-announcementslab-matters
Open data to power up the blue economy
People & Perspectives EMBL-EBI Senior Scientist Rob Finn explains why data coordination and sharing are fundamental for a sustainable blue economy.
2023
people-perspectivesperspectivesscience
Supporting the development of hologenomic approaches for more sustainable animal feeds
Science & Technology HoloFood, the first consistent collection of multiomic data about chicken and salmon gut microbiomes, set to enable the development of better animal feeds.
2023
sciencescience-technologytechnology-and-innovation
EMBL alumni: Alex Almeida on the unchartered gut microbiome and becoming a principal investigator
People & Perspectives As a postdoc Alex Almeida used bioinformatics to push the boundaries of what we know about the gut microbiome. Here, Almeida explains how his time at EMBL-EBI generated new research avenues, and how the skills and connections from his postdoc prepared him for leading his own research group at the…
2023
people-perspectivesperspectives
Molecules to Ecosystems: Rob Finn on the Microbial Ecosystems transversal theme
Lab MattersPeople & Perspectives Rob Finn, one of the co-chairs of the Microbial Ecosystems theme, discusses his work, the challenges of multidisciplinary research, and how the theme is already helping to promote the exchange of scientific ideas.
2023
lab-matterspeople-perspectives
EMBL scientists receive prestigious ERC Starting Grant
EMBL AnnouncementsLab Matters Three EMBL scientists received this year’s ERC Starting Grants, and will be awarded €1.5 million over five years to carry out research projects.
2022
embl-announcementslab-matters
Welcome Jordi van Gestel
Lab MattersPeople & Perspectives Looking to understand microbial predator-prey relationships, EMBL’s newest group leader tackles a molecular ‘arms race’ in his lab.
2022
lab-matterspeople-perspectives
When microbiomes collide
Science & Technology EMBL researchers used data from over 300 human faecal microbiota transplants to gain an ecological understanding of what happens when two gut microbiomes clash.
2022
sciencescience-technology
Shining a light on how bacteria interact
Science & Technology Machine learning has helped researchers uncover new insights into how bacteria infect host cells.
2022
research-highlightssciencescience-technology
The retron switch
Science & Technology EMBL researchers now understand the function of an elusive small DNA in bacteria and have developed a tool that can be used to better understand what might ‘switch on’ bacterial immune defences.
2022
sciencescience-technology
Three EMBL scientists elected as EMBO Members
EMBL AnnouncementsLab Matters Cornelius Gross, Miki Ebisuya and Nassos Typas join EMBO, the prestigious organisation for the life sciences.
2022
embl-announcementslab-matters
Welcome: Pascale Cossart
Lab MattersPeople & Perspectives Pascale Cossart, one of the world’s foremost authorities on the biology of Listeria, brings four decades of expertise in intracellular bacterial parasitism to EMBL as a visiting scientist.
2022
lab-matterspeople-perspectives
Welcome: John Lees
Lab MattersPeople & Perspectives John Lees joins EMBL-EBI as a Group Leader in Pathogen informatics and modelling.
2022
lab-matterspeople-perspectives
A new era for European molecular biology
EMBL AnnouncementsLab Matters EMBL announces details about its next programme, ‘Molecules to Ecosystems’. It will guide studying life across scales and in context with changing environments.
2022
announcementsembl-announcementslab-matters
Welcome: Maria Zimmermann-Kogadeeva
Lab MattersPeople & Perspectives Maria Zimmermann-Kogadeeva is one of EMBL’s newest group leaders and a computational biologist whose research group applies computational modelling to better understand the metabolism of gut bacteria and their potential to have far-reaching impacts on other organs.
2021
lab-matterspeople-perspectives
Tackling the collateral damage from antibiotics
Science & Technology Researchers from EMBL’s Typas group and collaborators have analysed the effects of 144 antibiotics on the wellbeing of gut microbes. The study improves our understanding of antibiotics’ side effects and suggests a new approach to mitigating the adverse effects of antibiotics therapy on gut…
2021
sciencescience-technology
Common medications accumulate in gut bacteria
Science & Technology A new collaborative study led by EMBL group leaders Kiran Patil, Nassos Typas, and Peer Bork has found that common medications accumulate in human gut bacteria. This process reduces drug effectiveness and affects the metabolism of common gut microbes, thereby altering the gut microbiome.
2021
sciencescience-technology
Joining forces to solve global challenges
ConnectionsLab Matters EMBL and the Swedish Science for Life Laboratory sign agreement to advance science together.
2021
connectionslab-matters
No matching posts found
